Dvago Logo
    location icon

    Dvago Logo

    Delivers in

      location icon


      Toujeo Solo Star 1.5Ml

      Rs. 2,888.12

      Rs. 3,040.13



      Toujeo Solo Specification

      Requires Prescription (YES/NO)



      Insulin glargine

      Used For

      Diabetes Management

      How it works

      The primary activity of insulin glargine is the regulation of glucose metabolism. It inhibits hepatic glucose production and lowers blood glucose level by enhancing peripheral glucose uptake especially by skeletal muscle and fat. It also inhibits lipolysis in the adipocyte, inhibits proteolysis and enhances protein synthesis

      Toujeo Solo Usage And Safety


      Insulin glargine

      Side Effects

      Very Common: Hypoglycemia is the most frequently occurring undesirable effect of insulin therapy that a patient with diabetes may suffer. Common: Lipohypertrophy, injection site reactions such as redness,pain, itching, swelling or inflammation. Uncommon: Lipoatrophy. Rare: Allergic reaction, visual impairment, retinopathy, edema (insulin may cause sodium retention and edema particularly if previously poor metabolic control is improved by intensified insulin therapy). Very Rare: Myalgia, dysgeusia.

      Drug Interactions

      Oral antidiabetic agents, angiotensin converting enzyme (ACE) inhibitors, disopyramide, fibrates, fluoxetine, monoamine oxidase (MAO) inhibitors, pentoxifylline, propoxyphene, salicylates and sulfonamide antibiotics , Drugs that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, estrogens and progestogens, phenothiazine derivatives, somatropin, sympathomimetic agents (e.g., epinephrine, salbutamol, terbutaline), thyroid hormones, atypical antipsychotic medicinal products (e.g., clozapine and olanzapine) and protease inhibitors , Beta-blockers, clonidine, lithium salts or alcohol , Pentamidine , sympatholytic drugs such as betablockers, clonidine, guanethidine and reserpine.


      Insulin Glargine is indicated for once daily subcutaneous administration for the treatment of: *Adult and Pediatric patients with Type I Diabetes Mellitus. *Adult patients with Type II Diabetes Mellitus who require basal (long-acting) insulin for the control of hyperglycemia.

      When not to Use

      Insulin Glargine must not be used in patients hypersensitive to insulin glargine or any of its excipients.

      Toujeo Solo Precautions


      Glucose monitoring is essential for all patients receiving insulin therapy. Changes to an insulin regimen should be made cautiously and only under medical supervision.

      Toujeo Solo Warnings

      Warning 1

      In case of insufficient glucose control or a tendency to hyperglycaemic or hypoglycaemic episodes, the patient's adherence to the prescribed treatment regimen, injection sites, proper injection technique and all other relevant factors must be reviewed before the consideration of dose adjustment.

      Warning 2

      Insulin requirements may be altered during illness or emotional disturbance, these situations may necessitate intensified metabolic monitoring and possibly, further special measures (e.g., dose adjustment, urine tests for ketones).

      Warning 3

      As with all insulins, the time course of insulin glargine action may vary in different individuals or at different times in the same individual and the rate of absorption are dependent on blood supply, temperature and physical activity. All factors increasing such risk require particularly close monitoring and may necessitate dose adjustment.

      Toujeo Solo Additional Information

      Pregnancy category

      Always consult your physician before using any medicine.

      Storage (YES/NO)

      Store in a refrigerator (2°C–8°C). Do not Freeze .

      Related Products